Gastric cancer, Precancerous Lesions of Gastric Cancer
Conditions
Interventions
CNAG group:None
CAG group:None
GAC group:None
PLGC group:None
Sponsors
Hainan Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. =35 years old; gender is not limited. 2. The diagnosis of chronic non-atrophic gastritis (CSG), chronic atrophic gastritis (CAG), precancerous lesions of gastric cancer (PLGC), and gastric adenocarcinoma (GC) is established through gastroscopy and examination of gastric mucosal pathology and histology. 3. It is possible to have effective communication. 4. Informed consent, voluntary participation.
Exclusion criteria
Exclusion criteria: 1. Received drug treatment research within the past month. 2. The combination of autoimmune gastritis (Type A chronic atrophic gastritis), peptic ulcers (Stage A1-H2), gastroesophageal reflux disease, gastric polyps, hypertrophic gastritis, and ulcerative colitis. 3. Individuals with gastric cancer other than gastric adenocarcinoma include those with gastric signet ring cell carcinoma (SRCC), gastric cardia cancer (GCC), gastric mucinous cell carcinoma, etc. 4. Patients with malignant tumors who have undergone surgery, radiation therapy, or chemotherapy within the last 5 years. 5. Combination of severe organic illnesses, including cardiac conditions (NYHA class III-IV heart failure, hemodynamically unstable myocardial infarction, etc.), liver problems (cirrhosis, etc.), renal problems (chronic kidney failure, uremia, etc.), renal problems (chronic kidney failure, uremia, etc.), pulmonary diseases (tuberculosis, acute asthma attack, lung infection, etc.), and autoimmune disorders (systemic lupus erythematosus, etc.). 6. Allergies or multiple drug sensitivities. 7. People with concurrent serious mental disorders who are unable to participate in the study due to conditions such as schizophrenia, depression, anxiety, and dementia. 8. Existing pregnancy or breastfeeding. 9. Non-cooperative survey participants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM syndrome information;Key molecular markers (LYZ, SST);Gastroscope Report;Pathological Report;Serological markers; | — |
Secondary
| Measure | Time frame |
|---|---|
| Prognostic information;Epidemiological information; | — |
Countries
China
Contacts
Public ContactJinglin Pan
Hainan Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed